Skip to menu Skip to content Skip to footer

You're viewing this site as a domestic an international student

You're a domestic student if you are:

  • a citizen of Australia or New Zealand,
  • an Australian permanent resident, or
  • a holder of an Australian permanent humanitarian visa.

You're an international student if you are:

  • intending to study on a student visa,
  • not a citizen of Australia or New Zealand,
  • not an Australian permanent resident, or
  • a temporary resident (visa status) of Australia.
You're viewing this site as a domestic an international student
Change

Engineering non-viral gene delivery methods for iPSC-derived Alzheimer’s models

This project is closed.

Project summary

Program
PhD
Location
St Lucia
Research area
Biological sciences, Biomedical and clinical sciences

Project description

Induced pluripotent stem cells (iPSCs) have emerged as a powerful tool for regenerative medicine and disease modelling, particularly for complex, age-related disorders like Alzheimer’s disease. However, reprogramming efficiencies remain extremely low, and iPSC’s often exhibit high heterogeneity in genomic stability and epigenetic status. These factors critically impact downstream differentiation quality and reproducibility. Additionally, studies have demonstrated that reprogramming is highly stressful for cells, causing DNA damage, and that reprogramming machineries are intertwined with mechanisms controlling DNA damage response, apoptosis and cell cycle. For example, the process of iPSC generation and reprogramming has been demonstrated to be facilitated by cell-death machinery such as the apoptosis-inducing caspases. Further, downregulation of TP53, the ‘cellular gatekeeper’ has also been shown to increase reprogramming efficiencies, although complete knockout has been associated with genomic instability. Although non-integrative vectors such as Sendai virus or episomal plasmids aim to reduce mutational burden, whole-genome sequencing reveals that reprogramming still introduces genetic aberrations. Fundamentally, the molecular mechanisms underpinning cellular reprogramming remain poorly understood and there is little to no information regarding how the delivery method and agent itself impacts the intracellular responses such as DNA damage, immune activation, and cell fate decisions.

This project aims to engineer precise, non-viral gene delivery systems using a technique called ‘DNA origami' to address these challenges and advance iPSC technologies for Alzheimer’s disease modelling. The student will develop a library of DNA origami constructs encoding transcription factors and epigenetic editing tools. Using cutting-edge approaches including super-resolution imaging, NanoSIMS, and single-cell multi-omics (including RNA-seq), the intracellular uptake, trafficking, and cellular responses to DNA origami will be characterised. In particular, the intracellular protein corona will be investigated by delivering DNA origami, fixing cells at various time points, performing pulldown assays, and analysing bound proteins by LC-MS/MS. Innate immune activation, such as through the cGAS-STING pathway, and DNA damage responses will be assessed through imaging and molecular assays. Dual DNA barcodes encoded in the origami constructs will enable multiplexed single-cell tracking of both delivery and gene expression. This comprehensive, correlative approach will provide critical insights into the intracellular barriers of non-viral delivery, enabling more efficient, stable, and scalable iPSC reprogramming for Alzheimer’s disease research.

This scholarship is part of the MIND-AD CRE Scholarship program which will support three students across its advertised projects. Applicants will be required to submit an online application and attend an interview.

Scholarship

This is an Fellowship support scheme scholarship project that aligns with a recently awarded Australian Government grant.

The scholarship includes:

  • living stipend of $36,400 per annum tax free (2025 rate), indexed annually
  • your tuition fees covered
  • single overseas student health cover (OSHC).

Learn more about the Fellowship support scheme scholarship.

Supervisor

Preferred educational background

Your application will be assessed on a competitive basis.

We take into account your:

  • previous academic record
  • publication record
  • honours and awards
  • employment history

A working knowledge of cellular or molecular biology, microscopy and data analysis would be of benefit to someone working on this project.

How to apply

This project requires candidates to commence no later than Research Quarter 2, 2026. You can start in an earlier research quarter.

You must submit an expression of interest (EOI) by the closing date for the research quarter (RQ) you want to start in:

  • RQ 1 (January): 30 September
  • RQ 2 (April): 31 December
  • RQ 3 (July): 31 March
  • RQ 4 (October): 30 June.
  • RQ 1 (January): 30 June
  • RQ 2 (April): 30 September
  • RQ 3 (July): 31 December
  • RQ 4 (October): 31 March.

Before you apply

  1. Check your eligibility for the Doctor of Philosophy (PhD).
  2. Prepare your documentation.
  3. If you have any questions about whether the project is suitable for your research interests, contact Professor Jurgen Götz (j.goetz@uq.edu.au).

When you apply

To apply, submit an expression of interest (EOI) for the program. You don't need to apply separately for the project or scholarship. How to submit an EOI

In your EOI, complete the 'Scholarship/Sponsorship' section with the following details:

  1. Are you applying for an advertised project: 'Yes'
  2. Project: 'Fellowship project scholarship'
  3. Scholarship Code Listed in the Advertisement: GOTZ-120725
  4. Link to Scholarship Advertisement: https://study.uq.edu.au/study-options/phd-mphil-professional-doctorate/projects/engineering-non-viral-gene-delivery-methods-ipsc-derived-alzheimers-models

Submit an EOI

This project is not available to international students